# AIRIS PHARMA PRIVATE LIMITED – FDA Inspection, Jan 31, 2017

Source: https://www.keypedia.com/records/fda_inspections/airis-pharma-private-limited/b86bbfe7-d68c-4e5e-8799-d0e6d4a6e6c8
Source feed: FDA_Inspections

> FDA inspection 1002512 of AIRIS PHARMA PRIVATE LIMITED, January 31, 2017. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1002512
- Company Name: AIRIS PHARMA PRIVATE LIMITED
- Inspection Date: 2017-01-31
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1228622 - 2024-02-03](https://www.keypedia.com/records/fda_inspections/airis-pharma-private-limited/8d3d39f3-fb15-49b4-90bd-a2a0cfbaf3be)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/tracey-l-harris/08c88ca9-370f-4c6b-9e9d-04a5c24486ec)

Company: https://www.keypedia.com/companies/airis-pharma-private-limited/fcbdc54b-e886-4781-a723-bf4bcf9c537d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c